Company Filing History:
Years Active: 2002
Title: Innovator Spotlight: Steven Blechner
Introduction: Steven Blechner is an accomplished inventor based in West Bridgewater, MA. He has made significant contributions to the field of pharmaceuticals, focusing on the development of innovative compositions and methods that can improve treatment for various pathologies.
Latest Patents: Steven holds a patent titled "Pharmaceutical compositions thereof, and methods of using same." This invention is centered on peptidomimetics capable of inhibiting the interaction between CD28/CTLA-4 and CD80/CD86, with a core amino acid sequence of LeuMetTyrProProProTyrTyr, corresponding to residues 2 to 9 of SEQ ID NO:1. The patent describes pharmaceutical compositions and methods for treating disorders that benefit from the inhibition of these interactions.
Career Highlights: Steven is affiliated with Applied Research Systems Ars Holding N.V., where he works on advancing pharmaceutical research and development. His innovative approach and dedication have helped pave the way for potential new therapies.
Collaborations: At Applied Research Systems, Steven collaborates with talented coworkers, including Nabil El Tayar and Brad Jameson. Together, they leverage their expertise to drive forward-thinking solutions in the pharmaceutical industry.
Conclusion: Steven Blechner's contributions to the field of pharmacology reflect his innovative spirit and commitment to improving patient outcomes. Through his patent and collaboration with industry peers, he continues to make strides in the development of impactful pharmaceutical solutions.